Forgot your password?

Forgot your username?

database > company
DUSA Pharmaceuticals
Biotech Specialty Pharma
25 Upton Drive
Wilmington, MA 01887 USA
phone:978-657-7500
fax:978-657-9193
Symbol DUSA
Exchange NASDAQ
Founded 0
Employees
www.dusapharma.com
Research Sector Biotech Specialty Pharma
Summary Description
Photodynamic Therapy for multiple medical conditions, with a primary focus on dermatology.
Management
Robert F. Doman, President and Chief Executive Officer; William F. O'Dell, Executive Vice President, Sales & Marketing; Richard Christopher, Vice President, Finance and Chief Financial Officer; Stuart Marcus, MD, PhD, Vice President, Scientific Affairs and Chief Medical Officer; Mark Carota, Vice President, Operations
Ownership
Financials Mkt Cap :68


* numbers in thousands
 

Keywords
dermatology, pre-cancerous, aminolevulinic, photosensitizer, protoporphyrin

Comment | Printable Version | Modify profile |
Updated: Oct. 17, 2011

Description
DUSA Pharmaceuticals, Inc. is a biopharmaceutical company engaged primarily in the development and marketing of Levulan Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical conditions, with a primary focus on dermatology. PDT and PD utilize light-activated compounds to induce a therapeutic or detection effect. DUSA is a world leader in PDT and PD, maintaining offices in Wilmington, MA, Valhalla, NY and Toronto, Ontario.
Products / Services
The Levulan Kerastick for Topical Solution plus blue light illumination using the BLU-U Blue Light Photodynamic Therapy Illuminator is indicated for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp.
Technology / Differentiation
Levulan Photodynamic Therapy (PDT) is a powerful, patented, versatile technology platform. When delivered to target tissues, Levulan (aminolevulinic acid HCl), is taken up and converted by fast growing cells into protoporphyrin IX (PpIX), a potent photosensitizer, which is then activated by an appropriate light source, such as the BLU-U blue light photodynamic therapy illuminator.
Market / Customers
Actinic Keratosis is a common skin condition caused by excessive sun exposure, especially in fair-skinned individuals. Acne


2012-02-07-750